Related references
Note: Only part of the references are listed.The Natural History of BK Polyomavirus and the Host Immune Response After Stem Cell Transplantation
Benjamin L. Laskin et al.
CLINICAL INFECTIOUS DISEASES (2020)
Hemorrhagic Cystitis after Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: Protective Effect of MESNA Continuous Infusion
Marcos Arango et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Presentation of BK polyomavirus-associated hemorrhagic cystitis after allogeneic hematopoietic cell transplantation
Hannah Imlay et al.
BLOOD ADVANCES (2020)
A prospective observational study of immune reconstitution following transplantation with post-transplant reduced-dose cyclophosphamide from HLA-haploidentical donors
Hirohisa Nakamae et al.
TRANSPLANT INTERNATIONAL (2019)
High incidence of BK virus-associated hemorrhagic cystitis in children after second or third allogeneic hematopoietic stem cell transplantation
Katsutsugu Umeda et al.
PEDIATRIC TRANSPLANTATION (2018)
The calcineurin inhibitor and the intensity of the conditioning regimen may affect the occurrence of polyomavirus-associated hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide
A. Rimondo et al.
BONE MARROW TRANSPLANTATION (2017)
Longer delay of hematological recovery and increased transfusion needs after haploidentical compared to non-haploidentical stem cell transplantation
A. Desjonqueres et al.
BONE MARROW TRANSPLANTATION (2016)
Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival
L. E. Lunde et al.
BONE MARROW TRANSPLANTATION (2015)
Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients
A. Ruggeri et al.
TRANSPLANT INFECTIOUS DISEASE (2015)
The risk of polyomavirus BK-associated hemorrhagic cystitis after allogeneic hematopoietic SCT is associated with myeloablative conditioning, CMV viremia and severe acute GVHD
J. Uhm et al.
BONE MARROW TRANSPLANTATION (2014)
High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation
L. Gilis et al.
BONE MARROW TRANSPLANTATION (2014)
Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of a Prospective Phase II Trial
Scott R. Solomon et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type
Leandro de Padua Silva et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
BK Virus Infection Is Associated with Hematuria and Renal Impairment in Recipients of Allogeneic Hematopoetic Stem Cell Transplants
Peter H. O'Donnell et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts
G. Giraud et al.
BONE MARROW TRANSPLANTATION (2008)
A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation
S. Cesaro et al.
BONE MARROW TRANSPLANTATION (2008)
BK virus infection in hematopoietic stem cell transplant recipients: Frequency, risk factors, and association with postengraftment hemorrhagic cystitis
V Erard et al.
CLINICAL INFECTIOUS DISEASES (2004)
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters
M El-Zimaity et al.
BLOOD (2004)
Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation
G Bogdanovic et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Share Paper
